SCHEMBL8435780

SCHEMBL8435780

COC(=O)c1cc(NC(C)=O)c(C)cc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
ALDH1A1 P00352 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
NPSR1 Q6W5P4 2/20 0.54
GALR2 O43603 1/20 0.54
MITF O75030 1/20 0.54
POLB P06746 1/20 0.54
HSP90AA1 P07900 1/20 0.54
HPGD P15428 1/20 0.54
XBP1 P17861 1/20 0.54
CCR6 P51684 1/20 0.54
KMT2A Q03164 3/20 0.49
PDGFRB P09619 1/20 0.48
FGFR1 P11362 1/20 0.48
PDGFRA P16234 1/20 0.48
FLT1 P17948 1/20 0.48
FGFR3 P22607 1/20 0.48
KDR P35968 1/20 0.48
HTT P42858 1/20 0.45
MAPT P10636 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2554500 0.89 KMT2A (0.55) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL13088438 0.88 SMN1; SMN2 (0.64) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL8954112 0.84 SMN1; SMN2 (0.58) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL11237157 0.83 POLB (0.60) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL12604704 0.83 PDGFRB (0.56) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL8767018 0.83 LMNA (0.58) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL7219587 0.82 ALDH1A1 (0.48) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL25504513 0.82 ALDH1A1 (0.53) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL10936842 0.82 MAPT (0.55) LMNAALDH1A1SMN1; SMN2NPSR1GALR2
SCHEMBL2929136 0.82 NPSR1 (0.51) LMNAALDH1A1SMN1; SMN2NPSR1GALR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO, INC. (CA) 2024-01-18 US disclosed
US-5928998-A PRE- AND POSTEMERGENCE HERBICIDES ZENECA LIMITED (GB) 1999-07-27 US disclosed
US-5444038-A Arylindazoles and their use as herbicides ZENECA LIMITED (GB) 1995-08-22 US disclosed
EP-0630367-A1 NOVEL ARYLINDAZOLES AND THEIR USE AS HERBICIDES ZENECA LIMITED (GB) 1994-12-28 EP disclosed
WO-1993018008-A1 NOVEL ARYLINDAZOLES AND THEIR USE AS HERBICIDES ZENECA LIMITED (GB) 1993-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF ABCG2, ABCB1, ARSA LMNA 992/4885ALDH1A1 653/4885SMN1; SMN2 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.